Conversely, switching APOE4 in sAD patient iPSCs to APOE3 was sufficient to alleviate most of the AD-related phenotypes in brain organoids, supporting the central role of APOE4 in sAD pathology [109]. Here, APOE is linked to Alzheimer disease.